SAN DIEGO, Feb. 25, 2021 /PRNewswire/ -- Genalyte, a
health care diagnostics and analytics company, and Sonora Quest
Laboratories, the market share leader in diagnostic laboratory
testing in Arizona, today
announced a strategic partnership with Cigna Medicare Arizona to
leverage science-based analytics to reduce costs while improving
clinical outcomes for customers of Cigna Arizona's Medicare
Advantage plans.
Genalyte's unique analytics approach applies both a causal and
associative model of data and clinical research to stratify a
population by health condition risk and clinical interventional
opportunities. Cigna's investment in advanced analytics will
further empower its clinicians and care teams to engage patients in
meaningful discussions about their health, chronic disease
management and risks, and personalized pathways to help mitigate
risk.
Genalyte's Predictive Analytics prospectively pinpoint patients
who should be targeted with diagnostic and therapeutic
interventions in the plan year.
"We are very excited about this partnership with Sonora Quest to
enable Cigna Medicare Arizona to identify customers who will likely
require clinical oversight to improve care and reduce costs," said
Hossein Fakhrai-Rad, the president
of BaseHealth Analytics at Genalyte.
"Genalyte's Health Engine paired with Sonora Quest's diagnostic
services can help health care providers identify who is likely to
become sick, why they will become sick, and the clinical
intervention to mitigate disease progression," said Dave Dexter, president and CEO of Sonora Quest
Laboratories. "Our priority continues to be helping patients and
their providers monitor, diagnose, and improve their health. We're
excited about this latest endeavor to expand our efforts."
"This is another great example of how collaboration can help to
advance and unlock the power of data in health care," added
Dan Hoemke, president of Cigna's Medicare Advantage plans in
Arizona. "Advanced analytics allow
clinicians, hospitals and customers to make timely and informed
decisions regarding care and can be critical to better health
outcomes. That is the result that we are driving toward with this
collaboration."
About Genalyte:
Genalyte is a health care diagnostics
and analytics company that improves patient outcomes and lowers
cost by offering real-time laboratory results for physicians and
patients. Genalyte delivers rapid, actionable results to doctors
through decentralized laboratory testing. For more information,
please visit www.genalyte.com.
About Sonora Quest Lab:
Sonora Quest Laboratories is a
leader in the diagnostic information business, offering a variety
of data–driven solutions to support our healthcare partners,
including a suite of Population Health solutions from enhanced data
delivery and analytics through the Actionable Insights Management
(AIM™) platform. Sonora Quest Laboratories, a joint venture between
Banner Health and Quest Diagnostics (NYSE: DGX), is part of the
nation's largest integrated laboratory system with approximately
3,500 employees serving more than 28,000 patients every day
throughout Arizona. Sonora Quest
Laboratories is the market share leader in clinical laboratory
testing in Arizona, performing
more than 85 million diagnostic tests per year. Sonora Quest
Laboratories offers a local comprehensive test menu which
encompasses routine, molecular, prescription drug monitoring,
genetic/genomic, women's health and pathology testing services. My
Lab ReQuest provides consumers direct access to a diverse range of
affordable screening tests that can be ordered online at
SonoraQuest.com or in any of Sonora Quest's 75 patient service
centers across Arizona.
Ninety-five percent of all testing is performed at the primary
testing facilities located in Phoenix, Tucson, Flagstaff, Prescott and Yuma. Sonora Quest Laboratories is accredited
by the College of American Pathologists (CAP), which is the gold
standard in laboratory accreditation, helping laboratories to
maintain accuracy of test results and ensure accurate patient
diagnosis. This accreditation ensures the highest standard of care
for all laboratory patients as CAP inspectors examine laboratory
staff.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/genalyte-and-sonora-quest-laboratories-partner-to-provide-predictive-analytics-for-cignas-medicare-advantage-plan-301235268.html
SOURCE Genalyte Inc